Healthy group | |
Age (years) | 60 (56.3–65.0) |
Gender (male) | 20 (66.7%) |
ASA status I; II; III; IV; V | 3 (10.0%); 16 (53.3%); 11 (36.7%); 0; 0 |
Surgical group | |
Age (years) | 60 (55.5-73.5) |
Gender (male) | 21 (67.7%) |
ASA status I; II; III; IV; V | 2 (6.7%); 16 (53.3%); 12 (40.0%); 0; 0 |
Site of surgery (double naming feasible) | |
 Liver | 8 (25.8%) |
 Pancreas | 14 (45.2%) |
 Gastrointestinal | 23 (74.2%) |
Septic group | |
Age (years) | 63.5 (53.8–73.0) |
Gender (male) | 23 (76.7%) |
SOFA score (at Onset) | 13.0 (12.0–14.5) |
APACHE II (at Onset) | 28.0 (25.3–32.8) |
Primary site of infection/septic focus (double naming feasible) | |
 Surgical focus | 28 (93.3%) |
 Medical focus | |
  Pneumonia | 5 (16.7%) |
  Urinary tract infection | 1 (3.3%) |
Outcome | |
 Survivor 30 days | 18 (60.0%) |